CCL17 and Alzheimer disease: Previous studies indicate candidate biomarkers reflecting the severity of AD, such as serum immunoglobulin E (IgE), thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), and total eosinophil count (TEC) (15, 16).